Condition: Advanced Pancreatic Carcinoma · Metastatic Pancreatic Carcinoma · Stage II Pancreatic Cancer AJCC v8 · Sponsor: Sameek Roychowdhury
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to other places in the body (metastatic) and that have abnormal changes (alterations) in the fibroblast growth factor receptor (FGFR) gene. FGFR genes are genes that, when altered, can lead to and promote the growth of cancer in patients. Researchers want to test if using pemigatinib can block the function of these abnormal FGFR genes and prevent the tumor from growing and whether treatment can help improve overall quality of life.
This description comes directly from the study's public registry record.
Sameek Roychowdhury, MD, PhD · 734-474-8359 · sameek.roychowdhury@osumc.edu
The Ohio State University Comprehensive Cancer Center and James Cancer Hospital · OSUCCCClinicaltrials@osumc.edu
Always discuss trial participation with your own doctor first.
| Ohio State University-Telemedicine | Birmingham, Alabama, United States | Recruiting |
| Ohio State University-Telemedicine | Mobile, Alabama, United States | Recruiting |
| Ohio State University Telemedicine | Montgomery, Alabama, United States | Recruiting |
| Ohio State University-Telemedicine | Anchorage, Alaska, United States | Recruiting |
| Ohio State University Telemedicine | Flagstaff, Arizona, United States | Recruiting |
| Ohio State University-Telemedicine | Phoenix, Arizona, United States | Recruiting |
| Ohio State University-Telemedicine | Tucson, Arizona, United States | Recruiting |
| Ohio State University-Telemedicine | Hot Springs, Arkansas, United States | Recruiting |
| Ohio State University Telemedicine | Fresno, California, United States | Recruiting |
| Ohio State University-Telemedicine | Los Angeles, California, United States | Recruiting |
| Ohio State University-Telemedicine | San Diego, California, United States | Recruiting |
| Ohio State University-Telemedicine | San Francisco, California, United States | Recruiting |
+ 97 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06906562